IL6 and Miyoshi myopathy: In other studies, the level of IL-6 was found to be significantly elevated in MM patients who have at least three visible lytic bone lesions and/or bone fracture in comparison to patients with one or two visible or no visible lytic bone lesions (p = 0.048) [23].